Long COVID, Regulating AI Medical Advice, and the Hidden Costs of Prior Authorization

Howie and Harlan discuss new research into the biological mechanisms behind long COVID and other post-infectious syndromes, how the FDA can ensure the safety of AI-powered medical tools, and why prior authorization can discourage necessary care even when treatments are ultimately approved. They also examine an early flu season, the changing calculus of COVID vaccination, and the continuing surge in measles cases.